EGPA: Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) as a special presentation of chronic rhinosinusitis with nasal polyps (CRSwNP).

Allergologie select Pub Date : 2024-03-21 eCollection Date: 2024-01-01 DOI:10.5414/ALX02475E
Jan Hagemann, Martin Laudien, Sven Becker, Mandy Cuevas, Felix Klimek, Roya Kianfar, Ingrid Casper, Ludger Klimek
{"title":"EGPA: Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) as a special presentation of chronic rhinosinusitis with nasal polyps (CRSwNP).","authors":"Jan Hagemann, Martin Laudien, Sven Becker, Mandy Cuevas, Felix Klimek, Roya Kianfar, Ingrid Casper, Ludger Klimek","doi":"10.5414/ALX02475E","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Eosinophilic granulomatosis with polyangiitis (EGPA) was formerly known as Churg-Strauss syndrome. The condition is characterized by disseminated necrotizing vasculitis with extravascular granulomas associated with hypereosinophilia. The vasculitides affect small vessels and are associated with antineutrophil cytoplasmic antibodies (ANCAs) detectable in the blood. Distinguishing between type 2-mediated chronic airway inflammation such as chronic rhinosinusitis with nasal polyps (CRSwNP) without vasculitis can be clinically challenging and should be considered.</p><p><strong>Materials and methods: </strong>Immunological background, diagnosis, and therapy of EGPA were identified through literature searches in Medline, PubMed, as well as national and international studies (ClinicalTrials.gov) and the Cochrane Library. Human studies published up to and including 10/2023 on the topic were considered.</p><p><strong>Results: </strong>In cases of deteriorating general health with previously known eosinophilic inflammation of the upper and lower airways, EGPA and its interdisciplinary investigation should be considered. Various types of eosinophilic inflammation and syndromes must be considered differentially.</p><p><strong>Conclusion: </strong>Characterization of mucosal airway inflammation through biomarker determination is meaningful and occasionally makes the difference for targeted therapy.</p>","PeriodicalId":101298,"journal":{"name":"Allergologie select","volume":"8 ","pages":"18-25"},"PeriodicalIF":0.0000,"publicationDate":"2024-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10975735/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Allergologie select","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5414/ALX02475E","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Eosinophilic granulomatosis with polyangiitis (EGPA) was formerly known as Churg-Strauss syndrome. The condition is characterized by disseminated necrotizing vasculitis with extravascular granulomas associated with hypereosinophilia. The vasculitides affect small vessels and are associated with antineutrophil cytoplasmic antibodies (ANCAs) detectable in the blood. Distinguishing between type 2-mediated chronic airway inflammation such as chronic rhinosinusitis with nasal polyps (CRSwNP) without vasculitis can be clinically challenging and should be considered.

Materials and methods: Immunological background, diagnosis, and therapy of EGPA were identified through literature searches in Medline, PubMed, as well as national and international studies (ClinicalTrials.gov) and the Cochrane Library. Human studies published up to and including 10/2023 on the topic were considered.

Results: In cases of deteriorating general health with previously known eosinophilic inflammation of the upper and lower airways, EGPA and its interdisciplinary investigation should be considered. Various types of eosinophilic inflammation and syndromes must be considered differentially.

Conclusion: Characterization of mucosal airway inflammation through biomarker determination is meaningful and occasionally makes the difference for targeted therapy.

EGPA:嗜酸性粒细胞肉芽肿伴多血管炎(Churg-Strauss 综合征)是慢性鼻炎伴鼻息肉(CRSwNP)的一种特殊表现。
简介嗜酸性粒细胞肉芽肿伴多血管炎(EGPA)以前被称为 Churg-Strauss 综合征。该病的特征是弥散性坏死性血管炎,伴有血管外肉芽肿和嗜酸性粒细胞增多。血管炎影响小血管,并伴有可在血液中检测到的抗中性粒细胞胞浆抗体(ANCA)。区分 2 型介导的慢性气道炎症(如慢性鼻炎伴鼻息肉(CRSwNP))与血管炎在临床上具有挑战性,应加以考虑:通过在 Medline、PubMed 以及国内和国际研究(ClinicalTrials.gov)和 Cochrane 图书馆中进行文献检索,确定了 EGPA 的免疫学背景、诊断和治疗。研究考虑了截至 2023 年 10 月(含 2023 年 10 月)发表的有关该主题的人类研究:结果:在全身健康状况恶化并伴有已知的上呼吸道和下呼吸道嗜酸性粒细胞炎症的病例中,应考虑进行 EGPA 及其跨学科调查。各种类型的嗜酸性粒细胞炎症和综合征必须区别对待:结论:通过生物标记物的测定来确定气道粘膜炎症的特征是非常有意义的,有时还能为靶向治疗带来不同的结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信